# US 2021/0268152 A1 · Conductive membrane for heart conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0268152 A1
- Document ID: US20210268152A1
- Status: Published application
- Kind: A1
- Application number: 17/326,216
- Filed: 2021-05-20
- Published: 2021-09-02
- Earliest claimed: 2013-02-05
- Assignees: University Health Network
- Applicants: University Health Network
- Inventors: Ren-Ke LI
- Web page: https://patentgrep.com/patent/US20210268152A1

## CPC

- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/20: Polysaccharides
- A61L 27/222: {Gelatin}
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 2430/20: for reconstruction of the heart, e.g. heart valves
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

The present disclosure relates to a biocompatible, electrically conductive membrane capable of carrying the electrical potential of a cardiac impulse. The present disclosure also relates to treatments using the electrically conductive polymer, such as for atrial fibrillation.

## Claims

### Claim 1

A biocompatible membrane comprising gelatin, a conductive polymer and a biocompatible component.

### Claim 2 (depends on 1)

The biocompatible membrane of claim 1, wherein the conductive polymer is selected from the group consisting of polyaniline-based polymers, polypyrrole-based polymers, polyethyleneoxide-based polymers, polythiophene-based polymers, and mixtures or copolymers thereof.

### Claim 3 (depends on 1)

The biocompatible membrane of claim 1, wherein the conductive polymer is polypyrrole or polyaniline.

### Claim 4 (depends on 1)

The biocompatible membrane of claim 1, wherein the biocompatible component is chitosan.

### Claim 5 (depends on 1)

The biocompatible membrane of claim 1, wherein the conducting polymer has a bulk specific conductance of greater than or equal to about 10−5 Siemens per centimeter.

### Claim 6 (depends on 1)

The biocompatible membrane of claim 1, wherein the material is a hydrogel.

### Claim 7 (depends on 6)

The biocompatible membrane of claim 6, wherein the hydrogel comprises a crosslinking agent.

### Claim 8 (depends on 7)

The biocompatible membrane of claim 7, wherein the gelatin, the conductive polymer and the biocompatible component form a uniform hydrogel.

### Claim 9 (depends on 1)

The biocompatible membrane of claim 1, comprising polypyrrole, chitosan and gelatin.

### Claim 10 (depends on 9)

The biocompatible membrane of claim 9, comprising 20%-80% polypyrrole-chitosan (PPY-CHI) by volume.

### Claim 11 (depends on 9)

The biocompatible membrane of claim 9, comprising 40%-60% PPY-CHI by volume.

### Claim 12 (depends on 9)

The biocompatible membrane of claim 9, comprising about 40% or about 60% PPY-CHI by volume.

### Claim 13 (depends on 9)

The biocompatible membrane of claim 9, further comprising a non-conductive membrane coupled to one surface of the uniform hydrogel.

### Claim 14 (depends on 1)

The biocompatible membrane of claim 1, wherein the membrane is prepared by:
mixing the conductive polymer and the biocompatible component in solution to form a copolymer solution;
allowing the conductive polymer and the biocompatible component to crosslink to in the presence of a cross-linking agent;
adding the copolymer solution to gelatin.

### Claim 15 (depends on 14)

The biocompatible membrane of claim 14, further comprising forming the copolymer solution/gelatin mix in a mold to produce a membrane having a predetermined shape and size.

### Claim 16 (depends on 9)

The biocompatible membrane of claim 9, wherein the membrane is 2 cm-10 cm in width, 2 cm-10 cm in length and 0.05 cm-0.4 cm thick.

### Claim 17 (depends on 9)

The biocompatible membrane of claim 9, wherein the membrane is 4 cm-8 cm in width, 4 cm-8 cm in length and 0.1 cm-0.3 cm thick.

### Claim 18 (depends on 9)

The biocompatible membrane of claim 9, wherein the membrane is about 6 cm in width, about 6 cm in length and about 0.2 cm thick.

### Claim 19 (depends on 9)

The biocompatible membrane of claim 9, wherein the membrane is shaped to adhere to a heart atrium.

### Claim 20 (depends on 9)

The biocompatible membrane of claim 9, wherein the membrane is shaped to adhere to a heart ventricle.

### Claim 21 (depends on 9)

The biocompatible membrane of claim 9, wherein the shape of the membrane is square, rectangular, elliptical, or circular.

### Claim 22 (depends on 1)

A method of treating a heart condition, the method comprising applying the biocompatible membrane of claim 1 to the heart.

### Claim 23 (depends on 22)

The method of claim 22, wherein the heart condition is myocardial infarction, heart failure, atrioventricular block, arrhythmia, atrial or ventricular fibrillation or a conduction abnormality.

### Claim 24 (depends on 22)

The method of claim 22, wherein the biocompatible membrane is applied to a surface of the heart.

### Claim 25 (depends on 22)

The method of claim 22, wherein the biocompatible membrane is applied to an atrium of the heart.

### Claim 26 (depends on 22)

The method of claim 22, wherein the biocompatible membrane is applied to a ventricle of the heart.
